Tianlong in Medlab 2023 | New Product Shines at Dubai
Release Date 2023-02-10


Medlab Middle East 2023, a leading exhibition of laboratory medicine in the ME region, was unveiled at Dubai World Trade Center from 6 to 9 February. 


As Tianlong’s first show of 2023, we are well prepared and thrilled to welcome guests from all over the world and discuss the latest innovations in the IVD industry. 


1686635937102197.jpg





Tianlong introduces to the audience our innovative PCR lab solution, covering nucleic acid extractors, real-time PCR systems, sample processing systems, liquid handling systems, and compatible reagents. The star products from Tianlong have got recognition from new and old partners for their excellent performance and stable quality.


1686635937102197.jpg1686635961851508.jpg

1686635962721036.jpg1686635964808929.jpg


This time, the journey to Medlab 2023 we have also launched our new product Panall 8000 All-in-one Molecular Diagnosis System and put it on the international stage. The new product has drawn the attention of a large number of customers to stop and watch.



-   Tianlong Panall 8000   -

The new lab booster, Tianlong Panall 8000 is a simple and secure molecular diagnosis system that integrates the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis, which can realize a true sample in - result out detection process and bring great convenience for professionals with only one-key operation.

Benefits

1

Sample in - result out system

2

One key operation and walkaway workflow

3

Closed system minimizes contamination

4

8 samples can be tested at the same time

5

12.1-inch intuitive touchscreen


It’s a great gathering in Dubai. Thanks to all our friends, partners, and colleagues for making Medlab 2023 a great success.


Tianlong will always excel in making excellent products, and thanks for choosing Tianlong. We’ll keep you informed of our latest shows and hope to have more interactions with you next time.

Share